Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said "We will export vaccines taking into account the domestic demand." By late July, there was still uncertainty in Nepal over when SII
| Attributes | Values |
|---|
| rdfs:label
| - COVID-19 vaccination in Nepal (en)
- 尼泊爾2019冠狀病毒病疫苗接種計劃 (zh)
|
| rdfs:comment
| - 尼泊尔的2019冠状病毒病疫苗接种计划始于2021年1月27日。印度提供了100万支疫苗作为赠品，而尼泊尔从印度血清研究所带来了100万支，同时政府决定很快购买下一批100万支。第一批货物的交付很迅速，100万剂疫苗于2月21日抵达。尼泊尔于2月15日批准国药集团的Vero细胞（BBIBP-CorV）紧急使用。中国曾承诺在赠款援助下提供80万剂国药集团的疫苗。中国的疫苗于3月29日抵达尼泊尔。尼泊尔从印度血清研究所带来了下一个100万份，而由于印度暂时禁止出口疫苗，正在进行的购买过程被停止了。目前正在与许多疫苗生产国，主要是美国和中国，进行谈判，以便尽快购买更多的疫苗。 (zh)
- Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said "We will export vaccines taking into account the domestic demand." By late July, there was still uncertainty in Nepal over when SII (en)
|
| foaf:homepage
| |
| foaf:depiction
| |
| dcterms:subject
| |
| Wikipage page ID
| |
| Wikipage revision ID
| |
| Link from a Wikipage to another Wikipage
| |
| Link from a Wikipage to an external page
| |
| sameAs
| |
| dbp:wikiPageUsesTemplate
| |
| thumbnail
| |
| organisers
| |
| outcome
| - * ' of the Nepalese population has received at least one dose.
* ' of Nepalese population has received full doses (en)
|
| caption
| - Oxford–AstraZeneca (Covishied), the most commonly used vaccine in Nepal (en)
|
| cause
| |
| date
| |
| location
| |
| participants
| - * 1,51,72,527 people with at least one dose administered
* 1,12,32,683 people have been fully vaccinated (en)
|
| target
| - Immunisation of Nepalese against COVID-19 (en)
|
| title
| - COVID-19 vaccination programme (en)
|
| website
| |
| has abstract
| - Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said "We will export vaccines taking into account the domestic demand." By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon." Nepal approved China's Sinopharm BIBP vaccine (BBIBP-CorV) for emergency use on 15 February. The first doses arrived in Nepal on 29 March. By July, China, had provided 1.8 million doses of the Sinopharm BIBP vaccine under grant assistance, and committed to providing another 1.6 million doses. Separately, the government purchased 4 million doses in June for which delivery was expected to be complete in a few days and was expected to purchase another 6 million doses in July. About 1.52 million doses of single dose Janssen vaccine (Johnson & Johnson) arrived on July as aid from the United States. Similarly, Ambassador Berry assured that the U.S. had prioritized additional vaccine assistance to Nepal realizing the need. Nepal on 25 October 2021 received 100,620 doses of Pfizer-BioNtech COVID-19 vaccine provided by the United States through COVAX. Nepal is set to receive 1.6 million doses of single dose Oxford AstraZeneca as aid from Japan. Nepal has requested additional 3 lakhs vaccine dosage from Bhutan which is under consideration. (en)
- 尼泊尔的2019冠状病毒病疫苗接种计划始于2021年1月27日。印度提供了100万支疫苗作为赠品，而尼泊尔从印度血清研究所带来了100万支，同时政府决定很快购买下一批100万支。第一批货物的交付很迅速，100万剂疫苗于2月21日抵达。尼泊尔于2月15日批准国药集团的Vero细胞（BBIBP-CorV）紧急使用。中国曾承诺在赠款援助下提供80万剂国药集团的疫苗。中国的疫苗于3月29日抵达尼泊尔。尼泊尔从印度血清研究所带来了下一个100万份，而由于印度暂时禁止出口疫苗，正在进行的购买过程被停止了。目前正在与许多疫苗生产国，主要是美国和中国，进行谈判，以便尽快购买更多的疫苗。 (zh)
|
| prov:wasDerivedFrom
| |
| page length (characters) of wiki page
| |
| foaf:isPrimaryTopicOf
| |
| is Link from a Wikipage to another Wikipage
of | |
| is Wikipage redirect
of | |
| is foaf:primaryTopic
of | |
_2021_cropped.jpg)
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)
